Why another drug development services company? The simple answer is that Aptuit is not just another drug development services company. Establishing Aptuit is the realization of a long-held belief in the commercial and technical value of innovation.

Our team sees a remarkable opportunity to bring innovation to the biopharmaceutical industry based on three key factors.

First, drug development as a process is in need of dramatic change. One by one, many functions in the upstream part of the research-to-commercialization process have been revolutionized in recent years. To name just a few examples, we now have proteomics-based biomarker discovery, high throughput screening, and combinatorial chemistry. But at the same time, drug development has remained intractably long and expensive, and total productivity — measured by numbers of new products reaching the marketplace — has dropped. Spending more than $800 million and 10+ years per drug on the development process simply isn't efficient or financially sustainable long-term even for large global pharmaceutical firms. Traditional management ideas need to be revisited to eliminate repetition, rework and excessive review.

Aptuit is committed to engineering a new drug development process.

Second, a critical mass of tools, ideas, people and technologies is becoming available right now. Surrogate markers of therapeutic impact, technology applications for measuring drug efficacy in real time, and microdosing to expedite early safety trials can all help bring about significant change. In the past, only the major pharmaceutical companies had the resources to scan the emerging technologies landscape and then acquire, assimilate, validate, and leverage them in a limited access application. Soon, smaller drug discovery innovators can look to Aptuit to provide a similar window into technology, innovation, and process improvement.

Aptuit will vigilantly identify new approaches that can save time and increase cost efficiency.

Third, no service provider has stepped up to the plate with a model that delivers integrated solutions. It is clear to us that horizontal management — across the technologies, procedures, data management, and regulatory compliance functions — is essential to the process, but most service providers are still organized according to the vertical silos of traditional drug development.

Aptuit brings a different mindset to the field, providing the 21st century value proposition that is needed to carry your product from discovery to commercialization.

Our management team has decades of experience, access to abundant financial and operating resources, and a truly fresh perspective. Keenly focused on providing unmatched customer service, we are determined to help get your product to market…either with a fully integrated package, or just the specific module you need.

Please call or email us at any time to discuss the direction of your product development and how Aptuit can help you along the way.

Sincerely,
Michael A. Griffith
Chief Executive Officer